Center for Disease Dynamics, Economics & Policy, 5636 Connecticut Ave NW, PO Box 42735, Washington, DC 20015, USA.
The Population Council, 1 Dag Hammarskjold Plaza, New York, NY 10017, USA.
Health Policy Plan. 2022 Feb 8;37(2):200-208. doi: 10.1093/heapol/czab114.
India's Universal Immunization Programme (UIP) is among the largest routine childhood vaccination programmes in the world. However, only an estimated 65% of Indian children under the age 2 years were fully vaccinated in 2019. We estimated the cost of raising childhood vaccination coverage to a minimum of 90% in each district in India. We obtained vaccine price data from India's comprehensive multi-year strategic plan for immunization. Cost of vaccine delivery by district was derived from a 2018 field study in 24 districts. We used propensity score matching methods to match the remaining Indian districts with these 24, based on indicators from the National Family Health Survey (2015-16). We assumed the same unit cost of vaccine delivery in matched pair districts and estimated the total and incremental cost of providing routine vaccines to 90% of the current cohort of children in each district. The estimated national cost of providing basic vaccinations-one dose each of Bacillus Calmette-Guerin (BCG) and measles vaccines, and three doses each of oral polio (OPV) and diphtheria, pertussis and tetanus vaccines-was $784.91 million (2020 US$). Considering all childhood vaccines included in UIP during 2018-22 (one dose each of BCG, hepatitis B and measles-rubella; four doses of OPV; two doses of inactivated polio; and three doses each of rotavirus, pneumococcal and pentavalent vaccines), the estimated national cost of vaccines and delivery to 90% of target children in each district was $1.73 billion. The 2018 UIP budget for vaccinating children, pregnant women and adults was $1.17 billion (2020 US$). In comparison, $1.73 billion would be needed to vaccinate 90% of children in all Indian districts with the recommended schedule of routine childhood vaccines. Additional costs for infrastructural investments and communication activities, not incorporated in this study, may also be necessary.
印度的全民免疫计划(UIP)是世界上最大的常规儿童疫苗接种计划之一。然而,2019 年,印度只有估计 65%的 2 岁以下儿童完全接种了疫苗。我们估计了将儿童疫苗接种覆盖率提高到每个地区至少 90%的成本。我们从印度全面多年免疫规划战略计划中获取了疫苗价格数据。根据 2015-16 年全国家庭健康调查(NFHS)的指标,我们从 24 个地区的 2018 年实地研究中得出了每个地区的疫苗接种成本。我们使用倾向得分匹配方法将其余的印度地区与这 24 个地区进行匹配,基于 NFHS 的指标。我们假设匹配地区的疫苗接种单位成本相同,并估计每个地区目前儿童群体中 90%的常规疫苗接种的总成本和增量成本。提供基本疫苗接种的估计国家成本-一剂卡介苗(BCG)和麻疹疫苗,以及三剂口服脊髓灰质炎(OPV)和白喉、百日咳和破伤风疫苗-为 7849.1 万美元(2020 年美元)。考虑到 2018-22 年 UIP 中包含的所有儿童疫苗(一剂 BCG、乙肝和麻疹-风疹疫苗;四剂 OPV;两剂灭活脊髓灰质炎疫苗;以及三剂轮状病毒、肺炎球菌和五联疫苗),每个地区目标儿童接种 90%的疫苗和接种费用估计为 17.3 亿美元。2018 年用于为儿童、孕妇和成年人接种疫苗的 UIP 预算为 11.7 亿美元(2020 年美元)。相比之下,需要 173 亿美元才能按照常规儿童疫苗接种时间表为印度所有地区的 90%的儿童接种疫苗。本研究未纳入的基础设施投资和宣传活动的额外费用也可能是必要的。